文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

三国整群随机对照试验:增强社交游戏提升学生归属感与心理健康的Lina方案

Three cluster randomised controlled trials in Portugal, Czechia and the United Kingdom to test the effectiveness and cost-effectiveness of an augmented social play intervention in schools to support real-world connection and sense of belonging (Lina trial protocol).
PubMed 文献 · Trials · 2026-06-03

Lina是一项针对12-13岁学生的多课时课堂干预,通过智能手机引导的合作面对面游戏增强归属感。

要点

  • Lina干预融合沉浸式叙事、增强现实与循证心理学,旨在提升课堂归属感。
  • 主要结局包括归属感、心理健康症状、幸福感、孤独感和病耻感。

核心结论

  • Lina干预有望改善青少年心理健康,并为不同国家学校情境的实施提供指导。

研究设计与样本

  • 在捷克、葡萄牙和英国中学开展三项平行混合II型整群实用随机对照试验。
  • 三项试验独立检验效能并独立分析。

关键数值与推荐

  • 效果评估在Lina完成时及6个月后进行。
  • 使用学生报告的特拉华学校氛围调查、青少年社交焦虑量表、患者健康问卷-8、社会意识子量表、WHO-5幸福感指数、UCLA孤独感量表和修订版同伴心理健康病耻感量表定制版。
  • 成本效果使用儿童健康效用9D和EQ-5D-Y-3L测量生活质量,并结合教师和/或学校记录的资源使用清单分析。

临床怎么用

  • Lina设计为在常规学校课程中由课堂教师实施。
  • 实施评估包括研究者观察、教师报告的可行性、可接受性和适宜性问卷及教师焦点小组。
  • 对照班在效果试验后由教师带领完成Lina。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mental ill-health and loneliness represent major challenges for today's youth, exacerbated by unprecedented societal demands, including concurrent socialisation in physical and digital worlds. A strong sense of belonging can buffer against these challenges, and in adolescents is largely constituted in schools. Augmented Social Play (ASP) involves smartphone-led cooperative face-to-face gameplay which integrates immersive storytelling, augmented reality, and evidence-based psychology to strengthen belonging. Building on this foundation, Lina is a multi-session intervention designed for classroom-based delivery during routine school lessons. METHODS: Three parallel hybrid type II cluster pragmatic randomised controlled trials will be conducted in secondary schools in Czechia, Portugal and the UK. The independently powered and analysed trials will examine the effectiveness of Lina-compared to standard lessons-in strengthening classroom belonging, reducing symptoms of mental ill-health and improving wellbeing, loneliness and stigma. Forty classes of students whose modal age is 12-13 years will participate in each country. Effectiveness will be examined on completion of Lina and after 6 months, using the student-report Delaware School Climate Survey, the Social Anxiety Scale for Adolescents, the Patient Health Questionnaire-8, the Social Awareness subscale of the Social-Emotional Learning Edition of the Strengths and Difficulties Inventory System, the WHO-5 Well-being Index, the UCLA Loneliness Scale and a tailored version of the Peer Mental Health Stigmatisation Scale-Revised. To examine cost-effectiveness, quality of life will be measured in a corresponding manner, using the Child Health Utility 9D and the EQ-5D-Y-3L, and analysed alongside bespoke resource-use inventories, completed via teachers and/or school records. An embedded developmental evaluation of implementation will draw on researcher observations of Lina, teacher-reported Feasibility, Acceptability and Appropriateness of Intervention questionnaires and teacher focus groups. A second developmental phase of implementation evaluation will follow the effectiveness trial, while control classes do Lina with their teachers. An integrated qualitative evaluation will examine students' experiences of Lina using individual interviews and focus groups, including a particular focus on students with characteristics that put their sense of belonging at risk. DISCUSSION: Findings will speak to the potential impact of Lina on youth mental health. They will also inform Lina implementation guidance for diverse national and international school contexts. TRIAL REGISTRY INFORMATION: This trial is prospectively registered with ISRCTN (Identifier: ISRCTN11613092), registered on 15 September 2025, https://doi.org/10.1186/ISRCTN11613092 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Malhotra T, Qureshi O, Barnard A, et al. Three cluster randomised controlled trials in Portugal, Czechia and the United Kingdom to test the effectiveness and cost-effectiveness of an augmented social play intervention in schools to support real-world connection and sense of belonging (Lina trial protocol). Trials. 2026. PMID: 42231355. doi:10.1186/s13063-026-09780-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。